STRATA Skin Sciences to Present at Three Upcoming Investor Conferences
November 05 2020 - 8:00AM
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical
technology company in Dermatology and Plastic Surgery dedicated to
developing, commercializing and marketing innovative products for
the treatment of dermatologic conditions, today announced Dr. Dolev
Rafaeli, Chief Executive Officer and Matthew Hill, Chief Financial
Officer will participate in the following investor conferences:
H.C. Wainwright
6th Annual Israel
Conference |
Date: |
|
Thursday,
November 12, 2020 |
Time: |
|
2:30 PM Eastern |
Format: |
|
Virtual Presentation |
The presentation will not be webcast. The
investor presentation will be available from the Investor Relations
page of the Company's website at www.strataskin.com
Oppenheimer MedTech Summit |
Date: |
|
Thursday,
November 12, 2020 |
Format: |
|
1x1 Meetings Only |
A.G.P. Virtual Healthcare
Symposium |
Date: |
|
Thursday,
November 19, 2020 |
Format: |
|
1x1 Meetings Only |
About STRATA Skin
Sciences, Inc.STRATA Skin Sciences is a medical technology
company in Dermatology and Plastic Surgery dedicated to developing,
commercializing and marketing innovative products for the treatment
of dermatologic conditions. Its products include the XTRAC® excimer
laser and VTRAC® lamp systems utilized in the treatment of
psoriasis, vitiligo and various other skin conditions.
The Company’s proprietary XTRAC® excimer laser
delivers a highly targeted therapeutic beam of UVB light to treat
psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma,
diseases, which impact over 35 million patients in the United
States alone. The technology is covered by multiple patents,
including exclusive rights for patents for the delivery of
treatments to vitiligo patients.
STRATA’s unique business model leverages
targeted Direct to Consumer (DTC) advertising to generate awareness
and utilizes its in-house call center and insurance advocacy teams
to increase volume for the Company’s partner dermatology
clinics.
The XTRAC business has used this proven DTC
model to grow its domestic dermatology partner network to over 789
clinics, with a worldwide installed base of over 2,000 devices. The
Company is able to offer 90% of DTC patients an introduction to
physicians prescribing a reimbursable solution, using XTRAC, within
a 10-mile radius of their house. The Company is a leader in
dermatology in-clinic business generation for its partners.
Investor Contacts:Leigh Salvo(415)
937-5404ir@strataskin.com
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Sep 2023 to Sep 2024